Unicycive Therapeutics (@unicycive) / X

Unicycive Therapeutics

169 posts

Unicycive Therapeutics

@unicycive

Unicycive Therapeutics accelerates healthcare innovation to deliver life-changing medicines for kidney patients. Clinical-stage biotech focused on CKD.

Los Altos, CA

Joined June 2020

Pinned
Unicycive Therapeutics
@unicycive
Jan 29
Today the FDA has accepted the NDA for our investigational oral phosphate binder for the treatment of hyperphosphatemia – a significant milestone in our efforts to help address the needs of patients with chronic kidney disease (CKD) on dialysis. This progress reflects the
00:00
1.3K
Unicycive Therapeutics
@unicycive
May 14
We’re always grateful for the opportunity to connect with so many individuals. Thank you to the @nkf for bringing together such a committed community of advocates, clinicians, researchers, and industry leaders at the #NKFClinicals. We’re proud to be part of these conversations
374
Unicycive Therapeutics
@unicycive
May 12
Today, we announced our financial results for the first quarter of 2026. With a potential FDA approval decision on the horizon, we remain focused on bringing forward new treatment options for chronic kidney disease patients with unmet needs. Learn more: ir.unicycive.com/news/detail/12…
227
Unicycive Therapeutics
@unicycive
Apr 24
We’ll be attending the American Nephrology Nurses Association (ANNA) Symposium and are looking forward to connecting with nephrology nurses and HCPs dedicated to improving care for patients with kidney disease. If you’re attending, stop by Booth 301 – we’d love to connect about
293
Unicycive Therapeutics
@unicycive
Apr 20
Events like the 2026 Renal Physicians Association Annual Meeting are an important opportunity to hear directly from those on the front lines of kidney care, and our Executive Director of Key Accounts Derrick Donald was on site this past week exchanging perspectives on the
144
Unicycive Therapeutics
@unicycive
Apr 15
We’re looking forward to attending the 2026 Renal Physicians Association Annual Meeting and joining others from across the nephrology community to talk about the challenges shaping kidney care. If you’re attending, we’d love to connect. #RPA2026
185
Unicycive Therapeutics
@unicycive
Apr 14
For people living with chronic kidney disease, elevated phosphorus levels can be a serious challenge – making education, awareness, and innovation in care more important than ever. At Unicycive, we’re committed to helping address urgent gaps in kidney care and advancing
234
Unicycive Therapeutics
@unicycive
Apr 10
Our CEO Shalabh Gupta, MD will be presenting at the virtual Needham & Company Healthcare Conference next week! We’re looking forward to sharing an update on our recent progress and key milestones as we work towards potential approval. Learn more: ir.unicycive.com/news/detail/12….
96
Unicycive Therapeutics
@unicycive
Mar 30
Today, we announced our financial results for the fourth quarter of 2025, as well as the results from the full year. We’re proud to share this update as we continue advancing our mission to close urgent gaps in kidney care. Learn more: ir.unicycive.com/news/detail/12…
173
Unicycive Therapeutics
@unicycive
Mar 2
This #NationalKidneyAwarenessMonth, we recognize the millions of people living with chronic kidney disease — and the families, caregivers, clinicians, and advocates who support them every day. We’re committed to advancing therapies and keeping patients at the center of
00:00
162
Unicycive Therapeutics
@unicycive
Feb 25
We're headed to the Annual Dialysis Conference – will we see you there? We’re looking forward to connecting with kidney care professionals from across the community and discussing what’s next in kidney disease and dialysis care and innovation. #AnnualDialysis
00:00
266
Unicycive Therapeutics
@unicycive
Feb 6
Our CEO @shalabhguptamd will participate in a fireside chat at the 2026 Guggenheim Emerging Outlook: Biotech Summit and discuss how we’re working towards approval of our potential new treatment for patients living with chronic kidney disease. Learn more and register:
259
Unicycive Therapeutics
@unicycive
Jan 14
Tomorrow at 2:40 p.m. PT, our CEO @shalabhguptamd and EVP of Corporate Strategy Douglas Jermasek will share a practical playbook for scaling a lean biotech, using chronic kidney disease in a crowded market as the case study. Learn more: fiercejpmweek.com/event/jpmorgan… #FierceJPMWeek
352